ADMA Biologics Inc vs Tyson Foods, Inc. — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while Tyson Foods, Inc. trades at $56.25 (market cap $19.85B). The key difference: Tyson Foods, Inc. is far larger — about 8.9× ADMA Biologics Inc's market cap, and Tyson Foods, Inc. pays a 3.62% dividend while ADMA Biologics Inc pays none. Which is the better fit depends on your goals.
| ADMA | TSN | |
|---|---|---|
Market Cap | $2.22B | $19.85B |
Sector | Health | Consumer Staples |
52-Week High | $20.38 | $68.75 |
52-Week Low | $7.60 | $50.72 |
Enterprise Value | $2.29B | $27.12B |
Dividend Yield | — | 3.62% |
Trailing returns across standard periods
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →Tyson Foods is the largest U.S. producer of processed chicken and beef. It's also a large producer of processed pork and protein-based products under the brands Jimmy Dean, Hillshire Farm, Ball Park, Sara Lee, Aidells, State Fair, and Raised & Rooted, to name a few. Tyson sells 81% of its products through various U.S. channels, including retailers (47% in fiscal 2021), food service (32%), and other packaged food and industrial companies (10%). In addition, 11% of the company's revenue comes from exports to Canada, Mexico, Brazil, Europe, China, and Japan.
Read more on TSN →